Mdm2 gene amplification in gastric cancer correlation with expression of mdm2 protein and p53 alterations

Modern Pathology

Volumn 13, Issue 6, 2000, Pages 621-626

  Günther, Thomas ^a   Schneider Stock, Regine ^a   Häckel, Carsten ^a   Kasper, Hans Udo ^a   Pross, Matthias ^a   Hackelsberger, Andreas ^a   Lippert, Hans ^a   Roessner, Albert ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Gastric cancer; Mdm2; P53

Indexed keywords

PROTEIN MDM2; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CLINICAL ARTICLE; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE LOCATION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR CLASSIFICATION;

EID: 0343193103     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880107     Document Type: Article

References (33)

1. Oliner JD, Kinzler KW, Melzer PS, George D, Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992;358:80-3.
2. Mietz JA, Unger T, Huibregtse JM, Howley PM. The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J 1992;11:5013-20.
3. Momand J, Zambetti GP, Olson DC, George D, Levine AJ. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992;69:1237-45.
4. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV-16 E6, and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993;75:495-505.
5. Lane DP. p53, guardian of the genome. Nature 1992;358: 15-6.
6. Chen JD, Lin JY, Levine AJ. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene. Mol Med 1995;1:141-2.
7. Picksley SM, Lane DP. The p53-mdm2 autoregulatory feedback loop - a paradigm for the regulation of growth control by p53. Bioassays 1993;15:689-90.
8. Wu XW, Bayle JH, Olson D, Levine A. The p53 mdm-2 autoregulatory feedback loop. Genes Dev 1993;7:1126-32.
9. Kubbutat MHG, Jones SN, Vousden KH. Regulation of p53 stability by mdm2. Nature 1997;387:299-303.
10. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997;387:296-9.
11. Leach FS, Tokino T, Meltzer P, Burrell M, Oliner JD, Smith S, et al. p53 mutation, and MDM 2 amplification in human soft tissue sarcomas. Cancer Res 1993;53:2231-4.
12. Patterson H, Gill S, Fisher C, Law MG, Jayatilake H, Fletcher CDM, et al. Abnormalities of the p53, mdm2 and dcc genes in human leiomyosarcomas. Br J Cancer 1994;69:1052-8.
13. Günther T, Schneider-Stock R, Ryš J, Niezabitowski A, Roessner A. P53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma: a comparative analysis with clinico-pathological factors. J Cancer Res Clin Oncol 1997;123:388-94.
14. Marchetti A, Buttitta F, Girlando S, Dalla Palma P, Pellegrini S, Fina P, et al. mdm 2 gene alterations and mdm 2 protein expression in breast carcinomas. J Pathol 1995a;175:31-8.
15. Marchetti A, Buttitta F, Pellegrini S, Merlo G, Chella A, Angeletti CA, et al. mdm 2 gene amplification and overexpression in non-small cell lung carcinomas with accumulation of the p53 protein in the absence of p53 gene mutations. Diagn Mol Pathol 1995b;4:93-7.
16. Blok P, Craanen ME, Dekker W, Offerhaus GJA, Tytgat GNJ. No evidence for functional inactivation of wild-type p53 protein by mdm2 overexpression in gastric carcinogenesis. J Pathol 1998;186(1):36-40.
17. Spiessl B, Beahrs OH, Hermanek P, Hutter RVP, Scheibe O, Sobin LH, et al., editors. UICC - TNM atlas. 3rd ed. 2nd Rev. Berlin: Springer-Verlag; 1992.
18. Laurén P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-94.
19. Vojtesek B, Bàrtek J, Midgley CA, Lane DP. An immunochemical analysis of the human nuclear phosphoprotein p53: new monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods 1992;152:237-44.
20. Kawai A, Noguchi M, Beppu Y, Yokoyama R, Mukai K, Hirohashi S, et al. Nuclear immunoreaction of p53 protein in soft tissue sarcomas. Cancer 1994;73:2499-505.
21. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
22. Budowle B, Chakraborty R, Giusti AM, Eisenberg AJ, Allen RC. Analysis of the variable number of tandem repeats locus D1S80 by the polymerase chain reaction followed by high resolution polyacrylamide gel electrophoresis. Am J Hum Genet 1991;48:137-44.
23. Orita M, Suzuki Y, Sekyia T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using polymerase chain reaction. Genomics 1989;5:874-9.
24. Goldmann D, Merril CR. Silver staining of DNA in polyacrylamide gels: linearity and effect of fragment size. Electrophoresis 1982;3:24-6.
25. Soussi T, Legros Y, Lubin R, Ory K, Schlichtholz B. Multifactorial analysis of p53 alteration in human cancer: a review. Int J Cancer 1994;57:1-9.
26. Fléjou J-F, Muzeau F, Potet F, Lepelletier F, Fékété F, Hénin D. Overexpression of the p53 tumor suppressor gene product in esophageal and gastric carcinomas. Pathol Res Pract 1994;190:1141-8.
27. Chen CY, Oliner JD, Zhan Q, Fornace AJ Jr, Vogelstein B, Kastan MB. Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc Natl Acad Sci U S A 1994;91:2684-8.
28. Ladanyi M, Cha C, Lewis R, Jhanwar SC, Huvos AG, Healey JH. MDM2 gene amplification in metastatic osteosarcoma. Cancer Res 1993;53:16-8.
29. Kovar H, Auinger A, Jug G, Aryee D, Zoubek A, Salzer-Kuntschik M, et al. Narrow spectrum and infrequent p53 mutations and absence of mdm2 amplification in Ewing tumours. Oncogene 1993;8:2683-90.
30. Kessis TD, Slebos RJ, Han SM, Shah K, Bosch XF, Munoz N, et al. P53 gene mutations and mdm2 amplification are uncommon in primary carcinomas of the uterine cervix. Am J Pathol 1993;143:1398-405.
31. Blok P, Craanen ME, Offerhaus GJA, Dekker W, Kuipers EJ, Meuwissen SG, et al. Molecular alterations in early gastric carcinomas. No apparent correlation with Helicobacter pylori status. Am J Clin Pathol 1999;111(2):241-7.
32. Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff VM, et al. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res 1994;54: 794-9.
33. Ranzani GN, Luinetti O, Padovan LS, Calistri D, Renault B, Burrel M, et al. P53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type. Cancer Epidemiol Biomarkers Prevent 1995;4:223-31.